VACBFNYKODE THERAPEUTICS AS
Price Chart
Loading chart...
About NYKODE THERAPEUTICS AS (VACBF)
NYKODE THERAPEUTICS AS (VACBF) is a Biotechnology company whose shares trade over-the-counter on the Pink tier.
Vaccibody is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies. The Company is a leader in the rapidly developing field of individualized cancer neoantigen vaccines and is using the Vaccibody technology to generate best-in-class therapeutics to treat cancers with a high unmet medical need. Further, the Company focuses its research on infectious diseases.
VACBF key facts
- Ticker symbol
- VACBF
- Market tier
- Pink
- Sector
- Healthcare
- Industry
- Biotechnology
- Country of incorporation
- NO
- Estimated market cap
- $77.97M (as of May 14, 2025)
- Shares outstanding
- 283,627,680
- Reporting standard
- International Reporting: Oslo Bors
- Audit status
- Audited
- Fiscal year end
- 12/31
Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with V
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for NYKODE THERAPEUTICS AS (VACBF) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Biotechnology Companies on OTC Markets
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Social Media
Business Details
Stock Details
Loading modules...